Biblio

Export 957 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
G. E. Smith, Chandler, M., Fields, J. A., Aakre, J., and Locke, D. E. C., “A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1459-1468, 2018.
S. L. Paulo, Ribeiro-Rodrigues, L., Rodrigues, R. S., Mateus, J. M., Fonseca-Gomes, J., Soares, R., Diógenes, M. J., Solá, S., Sebastião, A. M., Ribeiro, F. F., and Xapelli, S., “Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1183-1202, 2021.
L. Sannemann, Bartels, C., Brosseron, F., Buerger, K., Fliessbach, K., Freiesleben, S. Dawn, Frommann, I., Glanz, W., Heneka, M. T., Janowitz, D., Kilimann, I., Kleineidam, L., Lammerding, D., Laske, C., Munk, M. H. J., Perneczky, R., Peters, O., Priller, J., Rauchmann, B. - S., Rostamzadeh, A., Roy-Kluth, N., Schild, A. - K., Schneider, A., Schneider, L. - S., Spottke, A., Spruth, E. Jakob, Teipel, S., Wagner, M., Wiltfang, J., Wolfsgruber, S., Duezel, E., and Jessen, F., “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
L. Sannemann, Bartels, C., Brosseron, F., Buerger, K., Fliessbach, K., Freiesleben, S. Dawn, Frommann, I., Glanz, W., Heneka, M. T., Janowitz, D., Kilimann, I., Kleineidam, L., Lammerding, D., Laske, C., Munk, M. H. J., Perneczky, R., Peters, O., Priller, J., Rauchmann, B. - S., Rostamzadeh, A., Roy-Kluth, N., Schild, A. - K., Schneider, A., Schneider, L. - S., Spottke, A., Spruth, E. Jakob, Teipel, S., Wagner, M., Wiltfang, J., Wolfsgruber, S., Duezel, E., and Jessen, F., “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
L. Sannemann, Bartels, C., Brosseron, F., Buerger, K., Fliessbach, K., Freiesleben, S. Dawn, Frommann, I., Glanz, W., Heneka, M. T., Janowitz, D., Kilimann, I., Kleineidam, L., Lammerding, D., Laske, C., Munk, M. H. J., Perneczky, R., Peters, O., Priller, J., Rauchmann, B. - S., Rostamzadeh, A., Roy-Kluth, N., Schild, A. - K., Schneider, A., Schneider, L. - S., Spottke, A., Spruth, E. Jakob, Teipel, S., Wagner, M., Wiltfang, J., Wolfsgruber, S., Duezel, E., and Jessen, F., “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
N. Baazaoui, Flory, M., and Iqbal, K., “Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1385-1401, 2017.
M. Miyamoto, Kuzuya, A., Noda, Y., Ueda, S., Asada-Utsugi, M., Ito, S., Fukusumi, Y., Kawachi, H., Takahashi, R., and Kinoshita, A., “Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.”, J Alzheimers Dis, vol. 75, no. 1, pp. 173-185, 2020.
E. R. Fantoni, Chalkidou, A., Brien, J. T. O. ', Farrar, G., and Hammers, A., “A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 783-796, 2018.
E. R. Fantoni, Chalkidou, A., Brien, J. T. O. ', Farrar, G., and Hammers, A., “A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 783-796, 2018.
M. A. Hird, Egeto, P., Fischer, C. E., Naglie, G., and Schweizer, T. A., “A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 2, pp. 713-29, 2016.
T
A. Slachevsky, Guzmán-Martínez, L., Delgado, C., Reyes, P., Farías, G. A., Muñoz-Neira, C., Bravo, E., Farías, M., Flores, P., Garrido, C., Becker, J. T., Lopez, O. L., and Maccioni, R. B., “Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1595-1603, 2017.
A. Slachevsky, Guzmán-Martínez, L., Delgado, C., Reyes, P., Farías, G. A., Muñoz-Neira, C., Bravo, E., Farías, M., Flores, P., Garrido, C., Becker, J. T., Lopez, O. L., and Maccioni, R. B., “Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1595-1603, 2017.
A. Slachevsky, Guzmán-Martínez, L., Delgado, C., Reyes, P., Farías, G. A., Muñoz-Neira, C., Bravo, E., Farías, M., Flores, P., Garrido, C., Becker, J. T., Lopez, O. L., and Maccioni, R. B., “Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1595-1603, 2017.
M. E. Flanagan, Cholerton, B., Latimer, C. S., Hemmy, L. S., Edland, S. D., Montine, K. S., White, L. R., and Montine, T. J., “TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1549-1558, 2018.
R. Capozzo, Zoccolella, S., Frisullo, M. Elisa, Barone, R., Dell'Abate, M. Teresa, Barulli, M. Rosaria, Musio, M., Accogli, M., and Logroscino, G., “Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy.”, J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
L. Fani, Hilal, S., Sedaghat, S., Broer, L., Licher, S., Arp, P. P., van Meurs, J. B. J., M Ikram, K., and M Ikram, A., “Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study.”, J Alzheimers Dis, vol. 73, no. 2, pp. 707-714, 2019.
K. N. H. Nudelman, Lin, J., Lane, K. A., Nho, K., Kim, S., Faber, K. M., Risacher, S. L., Foroud, T. M., Gao, S., Davis, J. W., Weiner, M. W., and Saykin, A. J., “Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.”, J Alzheimers Dis, vol. 71, no. 1, pp. 33-43, 2019.
K. N. H. Nudelman, Lin, J., Lane, K. A., Nho, K., Kim, S., Faber, K. M., Risacher, S. L., Foroud, T. M., Gao, S., Davis, J. W., Weiner, M. W., and Saykin, A. J., “Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.”, J Alzheimers Dis, vol. 71, no. 1, pp. 33-43, 2019.
C. Bussè, Caffarra, P., Rossi, A., Zorzi, G., Fragiacomo, F., Camporese, G., Pompanin, S., Di Bernardo, G. Antonio, and Cagnin, A., “Testing Hippocampal Memory in Prodromal Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 64, no. 2, pp. 349-353, 2018.
M. W. Granger, Franko, B., Taylor, M. W., Messier, C., St George-Hyslop, P., and Bennett, S. A. L., “A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.”, J Alzheimers Dis, vol. 51, no. 3, pp. 757-73, 2016.
B. Irfan, Shammala, A. Abu, Alshaer, N., Nasser, E., Wajahath, M., Hamawy, A., Tahir, M., Khawaja, H., Khan, O., Fikry, K., Kaleem, A., Nasser, M., and Saleh, K. J., “There are dementia patients in Gaza too.”, J Alzheimers Dis, vol. 102, no. 2, pp. 317-320, 2024.
A. Winkler, Weimar, C., Jöckel, K. - H., Erbel, R., Dragano, N., Broecker-Preuss, M., Moebus, S., Führer-Sakel, D., and Dlugaj, M., “Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 797-807, 2016.
S. L. Hartley, Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., H Rosas, D., Klunk, W., and Christian, B., “Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.”, J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
J. Miron, Picard, C., Frappier, J., Dea, D., Théroux, L., and Poirier, J., “TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer's Disease and in Response to Hippocampal Deafferentation in Rodents.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1547-1556, 2018.
R. A. Sperling, Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., Park, D. C., Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., Thies, B., Morrison-Bogorad, M., Wagster, M. V., and Phelps, C. H., “Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”, Alzheimers Dement, vol. 7, no. 3, pp. 280-92, 2011.

Pages